Albert B Sabin Vaccine Institute Inc
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$13,740,804
Receivables (Non-Related)
54%
Cash & Equivalents
32%
Other Assets
6%
Investments
5%
Prepaid Expenses
3%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$5,389,842
Payables & Accruals
77%
Other Liabilities
19%
Deferred Revenue
3%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$6,516,853
$4,383,268
-33%
Receivables (Non-Related)
$6,454,584
$7,485,294
+16%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$306,415
$450,434
+47%
Investments
$523,902
$625,151
+19%
Property, Plant, & Equipment (net)
$553,870
$35,386
-94%
Other Assets
$1,029,892
$761,271
-26%
Total Assets
$15,385,516
$13,740,804
-11%
Liabilities
2023
2024
Change
Payables & Accruals
$1,711,692
$4,158,019
+143%
Grants Payable
-
-
-
Deferred Revenue
-
$184,172
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$1,365,150
$1,047,651
-23%
Total Liabilities
$3,076,842
$5,389,842
+75%
Net assets
2023
2024
Change
Restricted Net Assets
$6,741,587
$4,472,988
-34%
Unrestricted Net Assets
$5,567,087
$3,877,974
-30%
Net assets
2023
2024
Change
Net assets
+$12,308,674
+$8,350,962
-32%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)